Table 2. Comparison between the TIVA and inhalation groups.
TIVA group (n = 69) | Inhalation group (n = 87) | p value | |
---|---|---|---|
Patient variables | |||
Male, no. | 64 | 83 | 0.510 |
Age, yr | 52.80±10.93 | 52.11±8.82 | 0.667 |
BMI, kg/m2 | 24.07 ±4.00 | 23.66 ± 4.09 | 0.325 |
ASA class III | 9 | 7 | 0.426 |
Smoker, no | 22 | 25 | 0.803 |
Preop C/T | 19 | 34 | 0.180 |
Preop R/T | 22 | 30 | 0.864 |
Hypertension | 24 | 28 | 0.864 |
Diabetes mellitus | 10 | 14 | 0.959 |
Anesthesia variables | |||
Mean CVP, mmHg | 7.04 ± 3.13 | 8.53 ± 3.23 | 0.0039 |
Total U/O, ml | 1509.86 ± 1063.95 | 2074.48 ± 1115.10 | 0.0001 |
Total crystalloid, ml | 4172.46 ± 1534.95 | 5183.91 ± 1416.40 | < 0.0001 |
Total colloid, ml | 572.46 ± 335.14 | 994.25 ± 434.65 | < 0.0001 |
Blood loss, ml | 918.77 ± 656.84 | 859.71 ± 486.47 | 0.707 |
I/O, ml | 2316.30 ± 1056.73 | 3243.97 ± 1282.99 | < 0.0001 |
Anesthesia duration, hr | 11.02 ± 2.84 | 11.70± 1.96 | 0.017 |
BMI, Body mass index; ASA, classification of American society for anesthesiologist physical status; Smoker, current smoker at the time of admission; Preop C/T, Preoperative chemotherapy; Preop R/T, Preoperative radiotherapy; TIVA, Total Intravenous anesthesia; CVP, Central venous pressure; U/O, urine output;
I/O, total fluid balance; Significant at p < 0.05 level